Ayyildiz, A. (2023) “Co-administration of apigenin with doxorubicin enhances anti-migration and antiproliferative effects via PI3K/PTEN/AKT pathway in prostate cancer cells”, Experimental Oncology, 43(2), pp. 125–134. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-2.16096.